By Timothy S. Donahue
Top Takeaways:
- Portal upgrades: The FDA has added new features to its CTP Portal NextGen to streamline PMTA and substantial equivalence (SE) submissions.
- eSubmitter phaseout: After Nov. 14, manufacturers will no longer use eSubmitter for PMTA and SE submissions.
- Digital modernization: These enhancements are part of the FDA’s broader effort to modernize tobacco product submissions.
The U.S. Food and Drug Administration is expanding its online submission platform for tobacco product applications as it prepares to retire eSubmitter for two of the industry’s most widely used regulatory pathways.
The FDA announced enhancements to its Center for Tobacco Products (CTP) Portal NextGen, adding features to streamline the submission of Premarket Tobacco Product Applications (PMTAs) and Substantial Equivalence (SE) reports.
The latest updates allow applicants to upload entire folders and subfolders, assign labels to submission documents directly in the portal, and save contact information for future filings. According to the FDA, these improvements were developed in response to user feedback and are intended to improve efficiency and consistency throughout the application process.
The agency also confirmed that it will phase out eSubmitter for PMTA and SE submissions after Nov. 14, requiring manufacturers to use the web-based forms available through the CTP Portal NextGen for those application types.
Companies unable to use the online portal will continue to have access to downloadable PDF forms for PMTA and SE submissions. Meanwhile, eSubmitter will remain available for other regulatory filings—including ingredient listings and harmful and potentially harmful constituent (HPHC) reports—until those submission types are migrated to the web-based platform.
The transition marks another step in the FDA’s ongoing effort to modernize tobacco product regulation through electronic submissions. CTP Portal NextGen was introduced to replace legacy submission methods with browser-based forms, providing a more standardized process for manufacturers submitting regulatory applications.
The FDA said it plans to continue expanding the portal’s capabilities and will provide additional training materials and guidance as new submission types are added.
For manufacturers pursuing PMTAs or SE reports, the Nov. 14 transition date marks an important operational change, requiring companies to update internal regulatory workflows before eSubmitter support for those submissions ends. Although the changes do not alter the scientific or legal requirements for obtaining marketing authorization, they will affect how companies prepare and submit applications to the agency.
